TLR2 and TLR4 agonists induce production of the vasoactive peptide endothelin-1 by human dendritic cells

Molecular Immunology

Volumn 46, Issue 15, 2009, Pages 3178-3182

  Spirig, Rolf ^a   Potapova, Inga ^a   Shaw Boden, Jane ^a   Tsui, Janice ^b   Rieben, Robert ^a   Shaw, Sidney G ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Dendritic cells; Endothelin 1; Human; Inflammation; Toll like receptor

Indexed keywords

CALCITRIOL; DEXAMETHASONE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 4 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

CHOLECALCIFEROL; DENDRITIC CELLS; DEXAMETHASONE; DINOPROSTONE; DISULFIDES; ENDOTHELIN-1; GLUCOCORTICOIDS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNITY, INNATE; INDOLE ALKALOIDS; LIPOPOLYSACCHARIDES; OXYTOCICS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; VITAMINS;

EID: 68749095004     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.05.179     Document Type: Article

References (32)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Banz Y., Hess O.M., Robson S.C., Csizmadia E., Mettler D., Meier P., Haeberli A., Shaw S., Smith R.A., and Rieben R. Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1. Cardiovasc. Res. 76 (2007) 482-493
3. Ehrenreich H., Anderson R.W., Fox C.H., Rieckmann P., Hoffman G.S., Travis W.D., Coligan J.E., Kehrl J.H., and Fauci A.S. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J. Exp. Med. 172 (1990) 1741-1748
4. Goerdt S., and Orfanos C.E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10 (1999) 137-142
5. Guruli G., Pflug B.R., Pecher S., Makarenkova V., Shurin M.R., and Nelson J.B. Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops. Blood 104 (2004) 2107-2115
6. Ihrcke N.S., and Platt J.L. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J. Cell. Physiol. 168 (1996) 625-637
7. Jantsch J., Chakravortty D., Turza N., Prechtel A.T., Buchholz B., Gerlach R.G., Volke M., Glasner J., Warnecke C., Wiesener M.S., Eckardt K.U., Steinkasserer A., Hensel M., and Willam C. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J. Immunol. 180 (2008) 4697-4705
8. Johnson G.B., Brunn G.J., Kodaira Y., and Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4. J. Immunol. 168 (2002) 5233-5239
9. Kung A.L., Zabludoff S.D., France D.S., Freedman S.J., Tanner E.A., Vieira A., Cornell-Kennon S., Lee J., Wang B., Wang J., Memmert K., Naegeli H.U., Petersen F., Eck M.J., Bair K.W., Wood A.W., and Livingston D.M. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6 (2004) 33-43
10. Lan Y.Y., Wang Z., Raimondi G., Wu W., Colvin B.L., de Creus A., and Thomson A.W. Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J. Immunol. 177 (2006) 5868-5877
11. Levin E.R. Endothelins. N. Engl. J. Med. 333 (1995) 356-363
12. Luft T., Jefford M., Luetjens P., Toy T., Hochrein H., Masterman K.A., Maliszewski C., Shortman K., Cebon J., and Maraskovsky E. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100 (2002) 1362-1372
13. Nelson J.B., Hedican S.P., George D.J., Reddi A.H., Piantadosi S., Eisenberger M.A., and Simons J.W. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat. Med. 1 (1995) 944-949
14. Nieuwdorp M., van Haeften T.W., Gouverneur M.C., Mooij H.L., van Lieshout M.H., Levi M., Meijers J.C., Holleman F., Hoekstra J.B., Vink H., Kastelein J.J., and Stroes E.S. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55 (2006) 480-486
15. Penna G., and Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164 (2000) 2405-2411
16. Persson B.P., Rossi P., Weitzberg E., and Oldner A. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury. Shock (2009) [Epub ahead of print]
17. Piechota M., Banach M., Irzmanski R., Barylski M., Piechota-Urbanska M., Kowalski J., and Pawlicki L. Plasma endothelin-1 levels in septic patients. J. Intensive Care Med. 22 (2007) 232-239
18. Prins B.A., Hu R.M., Nazario B., Pedram A., Frank H.J., Weber M.A., and Levin E.R. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J. Biol. Chem. 269 (1994) 11938-11944
19. Riboldi E., Musso T., Moroni E., Urbinati C., Bernasconi S., Rusnati M., Adorini L., Presta M., and Sozzani S. Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J. Immunol. 175 (2005) 2788-2792
20. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179 (1994) 1109-1118
21. Sato K., Yamashita N., Baba M., and Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18 (2003) 367-379
22. Schwandner R., Dziarski R., Wesche H., Rothe M., and Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274 (1999) 17406-17409
23. Shaw S.G., Boden J.P., Biecker E., Reichen J., and Rothen B. Endothelin antagonism prevents diabetic retinopathy in NOD mice: a potential role of the angiogenic factor adrenomedullin. Exp. Biol. Med. (Maywood) 231 (2006) 1101-1105
24. Shaw S.G., and Boden P.J. Insulin resistance, obesity and the metabolic syndrome. Is there a therapeutic role for endothelin-1 antagonists?. Curr. Vasc. Pharmacol. 3 (2005) 359-363
25. Shaw S.G., Schmid M., and Casty A. Critical factors in the radioimmunoassay of endothelin-1, endothelin-3, and big endothelin-1 in human plasma. Anal. Biochem. 278 (2000) 143-149
26. Spirig R., van Kooten C., Obregon C., Nicod L., Daha M., and Rieben R. The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cells. J. Immunol. 181 (2008) 878-890
27. Steinman R.M., and Banchereau J. Taking dendritic cells into medicine. Nature 449 (2007) 419-426
28. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., and Simon J.C. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195 (2002) 99-111
29. Tsui J.C., Baker D.M., Biecker E., Shaw S., and Dashwood M.R. Altered endothelin-1 levels in acute lower limb ischemia and reperfusion. Angiology 55 (2004) 533-539
30. Woltman A.M., de Fijter J.W., Kamerling S.W., Paul L.C., Daha M.R., and van Kooten C. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol. 30 (2000) 1807-1812
31. Wu H., Chen G., Wyburn K.R., Yin J., Bertolino P., Eris J.M., Alexander S.I., Sharland A.F., and Chadban S.J. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117 (2007) 2847-2859
32. Wu J., Garami M., Cheng T., and Gardner D.G. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J. Clin. Invest. 97 (1996) 1577-1588